MUFG Americas Holdings Corp increased its position in shares of UnitedHealth Group Inc (NYSE:UNH) by 2.2% in the 3rd quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The firm owned 53,687 shares of the healthcare conglomerate’s stock after buying an additional 1,131 shares during the period. MUFG Americas Holdings Corp’s holdings in UnitedHealth Group were worth $11,667,000 at the end of the most recent reporting period.
Several other hedge funds and other institutional investors have also recently bought and sold shares of UNH. Nuveen Asset Management LLC grew its stake in UnitedHealth Group by 1,354.6% during the 2nd quarter. Nuveen Asset Management LLC now owns 8,540,562 shares of the healthcare conglomerate’s stock worth $2,083,983,000 after buying an additional 7,953,416 shares during the last quarter. Thoroughbred Financial Services LLC lifted its position in UnitedHealth Group by 25,321.4% during the 2nd quarter. Thoroughbred Financial Services LLC now owns 1,922,872 shares of the healthcare conglomerate’s stock worth $192,287,000 after acquiring an additional 1,915,308 shares during the period. Boston Partners lifted its position in UnitedHealth Group by 160.8% during the 2nd quarter. Boston Partners now owns 2,550,998 shares of the healthcare conglomerate’s stock worth $622,942,000 after acquiring an additional 1,572,711 shares during the period. Sanders Capital LLC lifted its position in UnitedHealth Group by 50.2% during the 2nd quarter. Sanders Capital LLC now owns 4,626,666 shares of the healthcare conglomerate’s stock worth $1,255,689,000 after acquiring an additional 1,546,140 shares during the period. Finally, Viking Global Investors LP lifted its holdings in shares of UnitedHealth Group by 28.6% in the 2nd quarter. Viking Global Investors LP now owns 4,812,185 shares of the healthcare conglomerate’s stock valued at $1,174,221,000 after buying an additional 1,071,149 shares during the period. 85.75% of the stock is owned by institutional investors and hedge funds.
In other news, Director Timothy Patrick Flynn acquired 2,000 shares of the business’s stock in a transaction on Wednesday, August 28th. The stock was bought at an average cost of $227.55 per share, for a total transaction of $455,100.00. Following the purchase, the director now owns 5,524 shares in the company, valued at $1,256,986.20. The purchase was disclosed in a filing with the Securities & Exchange Commission, which is available at this hyperlink. Also, Director Richard T. Burke sold 25,000 shares of the business’s stock in a transaction that occurred on Wednesday, October 16th. The stock was sold at an average price of $236.56, for a total value of $5,914,000.00. Following the sale, the director now owns 163,331 shares of the company’s stock, valued at $38,637,581.36. The disclosure for this sale can be found here. Over the last quarter, insiders have sold 33,177 shares of company stock valued at $7,842,582. 0.87% of the stock is owned by company insiders.
UnitedHealth Group (NYSE:UNH) last posted its quarterly earnings data on Tuesday, October 15th. The healthcare conglomerate reported $3.88 EPS for the quarter, topping the Thomson Reuters’ consensus estimate of $3.75 by $0.13. UnitedHealth Group had a return on equity of 25.30% and a net margin of 5.57%. The company had revenue of $60.35 billion during the quarter, compared to analyst estimates of $59.84 billion. During the same period in the previous year, the business earned $3.41 EPS. UnitedHealth Group’s quarterly revenue was up 6.7% on a year-over-year basis. Equities analysts expect that UnitedHealth Group Inc will post 14.96 EPS for the current fiscal year.
The company also recently disclosed a quarterly dividend, which will be paid on Tuesday, December 17th. Shareholders of record on Monday, December 9th will be paid a dividend of $1.08 per share. This represents a $4.32 annualized dividend and a yield of 1.69%. UnitedHealth Group’s dividend payout ratio (DPR) is currently 33.54%.
Several equities analysts have recently issued reports on UNH shares. Deutsche Bank started coverage on UnitedHealth Group in a report on Thursday, September 12th. They issued a “hold” rating and a $263.00 price objective for the company. Royal Bank of Canada set a $311.00 price objective on UnitedHealth Group and gave the company a “buy” rating in a report on Friday, July 19th. Cantor Fitzgerald set a $310.00 price objective on UnitedHealth Group and gave the company a “buy” rating in a report on Tuesday, October 15th. BMO Capital Markets cut UnitedHealth Group from an “outperform” rating to a “market perform” rating and decreased their price objective for the company from $292.00 to $249.00 in a report on Monday, September 30th. Finally, UBS Group cut their price target on UnitedHealth Group from $281.00 to $257.00 and set a “neutral” rating for the company in a research note on Thursday, October 17th. Five investment analysts have rated the stock with a hold rating and sixteen have issued a buy rating to the stock. The company presently has a consensus rating of “Buy” and a consensus target price of $283.84.
UnitedHealth Group Company Profile
UnitedHealth Group Incorporated operates as a diversified health care company in the United States. It operates through four segments: UnitedHealthcare, OptumHealth, OptumInsight, and OptumRx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health and well-being services to individuals age 50 and older, addressing their needs for preventive and acute health care services, as well as services dealing with chronic disease and other specialized issues for older individuals; and Medicaid plans, Children's Health Insurance Program, and health care programs; and health and dental benefits.
See Also: Leveraged Buyout (LBO)
Want to see what other hedge funds are holding UNH? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for UnitedHealth Group Inc (NYSE:UNH).
Receive News & Ratings for UnitedHealth Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for UnitedHealth Group and related companies with MarketBeat.com's FREE daily email newsletter.